Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed

Hong Shu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2844-8347; OpenAlex author ID A5100769853. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 6)
Trials
0
Grants
0
Labs led
1
Collaborators
19
Papers, trials and grants by year

2012: 1 paper · 2013: 2 papers · 2014: 5 papers · 2015: none · 2016: none · 2017: 1 paper

Papers 9

  1. Pancreatic Cancer Progression Relies upon Mutant p53-Induced Oncogenic Signaling Mediated by NOP14. Co-author DOI 10.1158/0008-5472.can-16-2339↗
  2. N-wasp in pancreatic ductal adenocarcinoma: associations with perineural invasion and poor prognosis. Last author DOI 10.1007/s00268-014-2500-8↗
  3. Alteration of the intrinsic apoptosis pathway is involved in Notch-induced chemoresistance to gemcitabine in pancreatic cancer. Last author DOI 10.1016/j.arcmed.2013.10.001↗
  4. Prognostic significance of epidermal growth factor-like domain 7 in pancreatic cancer. Last author DOI 10.1016/s1499-3872(14)60272-1↗
  5. Insulin-like growth factor 1 receptor (IGF-1R) as a target of MiR-497 and plasma IGF-1R levels associated with TNM stage of pancreatic cancer. Co-author DOI 10.1371/journal.pone.0092847↗
  6. CHIP is a novel tumor suppressor in pancreatic cancer through targeting EGFR. Co-author DOI 10.18632/oncotarget.1890↗
  7. Notch1 contributes to chemoresistance to gemcitabine and serves as an unfavorable prognostic indicator in pancreatic cancer. Last author DOI 10.1007/s00268-013-2010-0↗
  8. MLH1 as a direct target of MiR-155 and a potential predictor of favorable prognosis in pancreatic cancer. Last author DOI 10.1007/s11605-013-2230-5↗
  9. Induction, modulation and potential targets of miR-210 in pancreatic cancer cells. Last author DOI 10.1016/s1499-3872(12)60168-4↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lei You · 8 shared papers, 2013–2017 · strength 0.35
  2. Taiping Zhang · 7 shared papers, 2012–2014 · strength 0.28
  3. Yu-Pei Zhao · 7 shared papers, 2012–2014 · strength 0.28
  4. Li Zhou · 7 shared papers, 2012–2014 · strength 0.27
  5. Tianxiao Wang · 4 shared papers, 2013–2014 · strength 0.16
  6. Ge Chen · 3 shared papers, 2012–2014 · strength 0.11
  7. Yupei Zhao · 2 shared papers, 2014–2017 · strength 0.10
  8. Jianwei Xu · 2 shared papers, 2014 · strength 0.08
  9. Junchao Guo · 2 shared papers, 2014 · strength 0.08
  10. Xiao Hong Du · 2 shared papers, 2013–2014 · strength 0.08
  11. Ziwen Liu · 1 shared paper, 2017 · strength 0.06
  12. Yongxing Du · 1 shared paper, 2017 · strength 0.06
  13. Xiaoxia Ren · 1 shared paper, 2017 · strength 0.06
  14. Wenming Wu · 1 shared paper, 2014 · strength 0.04
  15. Min Li · 1 shared paper, 2014 · strength 0.04
  16. Zhe Cao · 1 shared paper, 2014 · strength 0.04
  17. Jingxuan Yang · 1 shared paper, 2014 · strength 0.04
  18. Wen-Jing Liu · 1 shared paper, 2013 · strength 0.04
  19. Weiyun Chen · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.